Immunomedics Sidesteps Securities Fraud Suit
New Jersey-based biopharmaceutical company Immunomedics Inc. on Thursday turned back allegations that it misled investors by concealing the deterioration of a major licensing agreement after a federal judge ruled the company...To view the full article, register now.
Already a subscriber? Click here to view full article